https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-hire-around-2000-employees-globally-by-2023-end-2023-03-10/ Skip to main content Exclusive news, data and analytics for financial market professionals Reuters home * World * Business * Legal * Markets * Breakingviews * Technology * Investigations * More My View Register * * * * * * * * * COVID-19 * Public Health * Health * Employment 1 minute readMarch 10, 20237:38 PM UTCLast Updated ago Moderna to hire around 2,000 employees amid mRNA development push Reuters A sign marks the headquarters of Moderna in Cambridge A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder/File Photo * Companies * Moderna Inc Follow * * * * * * * * March 10 (Reuters) - Moderna Inc (MRNA.O) said on Friday it was planning to hire about 2,000 employees globally by 2023-end and set up new offices on the U.S. West Coast, as it aims to scale up development of new products amid declining COVID vaccine sales. The COVID vaccine maker said it will open new offices in California and Seattle, adding that its Genomics unit will expand to south San Francisco. The latest move comes at a time when Moderna has been working on developing vaccines for skin cancer, flu and respiratory syncytial virus (RSV) using its mRNA technology, which if approved would significantly boost the biotech company that currently relies heavily on its COVID-19 shot. Last month, Moderna forecast rising costs for 2023 and a decline in COVID vaccine sales, raising concerns that the company could post a loss this year. The firm had about 3,900 full-time employees as of Dec. 31, according to a regulatory filing. Shares of the Cambridge, Massachusetts-based company were up more than 2% at $140.22 in afternoon trade. Reporting by Raghav Mahobe in Bengaluru; Editing by Anil D'Silva, Shinjini Ganguli and Shailesh Kuber * * * * * Our Standards: The Thomson Reuters Trust Principles. Read Next * Future of HealthcategoryUS FDA approves Pfizer's nasal spray for migraine, article with image8:07 PM UTC * WorldcategoryBritain's junior doctors prepare to strike over pay, burnout, article with video5:49 PM UTC * WorldcategoryUS House unanimously backs COVID origins information declassification, article with gallery6:17 PM UTC * Healthcare & PharmaceuticalscategoryBayer plans to spend $1 bln on US pharma R&D in 2023-US pharma head, article with image5:14 AM UTC refinitiv_image_desktop Business * Investor dash for cash pumps U.S. money market funds to record high - BofA, article with imageFinancecategory * March 10, 2023 * 11:33 AM UTC Assets invested in U.S. money market funds have reached a new all-time high of $4.9 trillion this year, as soaring short-term interest rates have sent investors rushing into cash, BofA Global Research said on Friday. * FinancecategoryCredit Suisse shares hit new all-time low as banks hit by U.S. fallout, article with image8:40 AM UTC * Aerospace & DefensecategoryBoeing to set up 737 freighter conversion facility in India, article with image10:01 AM UTC * Sustainable MarketscategoryFactbox: Energy firms bet big on carbon capture projects in U.S., Canada, article with gallery5:53 PM UTC * EnvironmentcategoryExclusive: Colombia's Amazon reserves suffer staffing delays, risking environmental damage, article with image 6:57 PM UTC Site Index Browse * World * Business * Legal * Markets * Breakingviews * Technology * Investigations, opens new tab * Lifestyle About Reuters * About Reuters, opens new tab * Careers, opens new tab * Reuters News Agency, opens new tab * Brand Attribution Guidelines, opens new tab * Reuters Leadership, opens new tab * Reuters Fact Check, opens new tab * Reuters Diversity Report, opens new tab Stay Informed * Download the App, opens new tab * Newsletters, opens new tab Information you can trust Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Follow Us * * * * * Thomson Reuters Products * Westlaw, opens new tab Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. * Onesource, opens new tab The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. * Checkpoint, opens new tab The industry leader for online information for tax, accounting and finance professionals. Refinitiv Products * Refinitiv Workspace, opens new tab Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. * Refinitiv Data Catalogue, opens new tab Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. * Refinitiv World-Check, opens new tab Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. * Advertise With Us, opens new tab * Advertising Guidelines, opens new tab * Cookies, opens new tab * Terms of Use, opens new tab * Privacy, opens new tab * Digital Accessibility, opens new tab * Corrections, opens new tab * Site Feedback, opens new tab All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. (c) 2023 Reuters. All rights reserved